{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:06Z","timestamp":1786981446907,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11060-023-04346-y","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T06:02:31Z","timestamp":1684994551000},"page":"439-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Outcomes of systemic bevacizumab in radiation-induced optic neuropathy, case series"],"prefix":"10.1007","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3639-3102","authenticated-orcid":false,"given":"Ahmad Mohammed","family":"AlAmeer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2618-4894","authenticated-orcid":false,"given":"James Brian","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-2120","authenticated-orcid":false,"given":"Andrew Rising","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8676-4292","authenticated-orcid":false,"given":"Amanda Dean","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"issue":"1","key":"4346_CR1","first-page":"36","volume":"52","author":"O Mihalcea","year":"2008","unstructured":"Mihalcea O, Arnold AC (2008) Side effect of head and neck radiotherapy: optic neuropathy. Oftalmologia 52(1):36\u201340","journal-title":"Oftalmologia"},{"issue":"3","key":"4346_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1442-9071.2004.00809.x","volume":"32","author":"NR Miller","year":"2004","unstructured":"Miller NR (2004) Radiation-induced optic neuropathy: still no treatment. Clin Exp Ophthalmol 32(3):233\u2013235. https:\/\/doi.org\/10.1111\/j.1442-9071.2004.00809.x","journal-title":"Clin Exp Ophthalmol"},{"key":"4346_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2022-322854","author":"AR Carey","year":"2022","unstructured":"Carey AR, Page BR, Miller N (2022) Radiation-induced optic neuropathy: a review. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjo-2022-322854","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"4346_CR4","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1007\/s00520-019-04699-z","volume":"27","author":"B Zheng","year":"2019","unstructured":"Zheng B, Lin J, Li Y, Zhuo X, Huang X, Shen Q et al (2019) Predictors of the therapeutic effect of corticosteroids on radiation-induced optic neuropathy following nasopharyngeal carcinoma. Support Care Cancer 27(11):4213\u20134219. https:\/\/doi.org\/10.1007\/s00520-019-04699-z","journal-title":"Support Care Cancer"},{"issue":"1","key":"4346_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNO.0b013e318276d4b8","volume":"33","author":"HS Chahal","year":"2013","unstructured":"Chahal HS, Lam A, Khaderi SK (2013) Is pentoxifylline plus vitamin E an effective treatment for radiation-induced optic neuropathy? J Neuroophthalmol 33(1):91\u201393. https:\/\/doi.org\/10.1097\/WNO.0b013e318276d4b8","journal-title":"J Neuroophthalmol"},{"issue":"8","key":"4346_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/s0161-6420(86)33617-0","volume":"93","author":"J Guy","year":"1986","unstructured":"Guy J, Schatz NJ (1986) Hyperbaric oxygen in the treatment of radiation-induced optic neuropathy. Ophthalmology 93(8):1083\u20131088. https:\/\/doi.org\/10.1016\/s0161-6420(86)33617-0","journal-title":"Ophthalmology"},{"issue":"2","key":"4346_CR7","first-page":"98","volume":"13","author":"FX Borruat","year":"1993","unstructured":"Borruat FX, Schatz NJ, Glaser JS, Feun LG, Matos L (1993) Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy. J Clin Neuroophthalmol 13(2):98\u2013101","journal-title":"J Clin Neuroophthalmol"},{"issue":"2","key":"4346_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/WNO.0b013e3182464c88","volume":"32","author":"A Malik","year":"2012","unstructured":"Malik A, Golnik K (2012) Hyperbaric oxygen therapy in the treatment of radiation optic neuropathy. J Neuroophthalmol 32(2):128\u2013131. https:\/\/doi.org\/10.1097\/WNO.0b013e3182464c88","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"4346_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1530\/eje.1.02161","volume":"154","author":"M Boschetti","year":"2006","unstructured":"Boschetti M, De Lucchi M, Giusti M, Spena C, Corallo G, Goglia U et al (2006) Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with cushing disease. Eur J Endocrinol 154(6):813\u2013818. https:\/\/doi.org\/10.1530\/eje.1.02161","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"4346_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.47102\/annals-acadmedsg.V35N3p151","volume":"35","author":"RL Levy","year":"2006","unstructured":"Levy RL, Miller NR (2006) Hyperbaric oxygen therapy for radiation-induced optic neuropathy. Ann Acad Med Singap 35(3):151\u2013157","journal-title":"Ann Acad Med Singap"},{"issue":"1","key":"4346_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/WNO.0b013e31820d5361","volume":"31","author":"MS Lee","year":"2011","unstructured":"Lee MS, Borruat FX (2011) Should patients with radiation-induced optic neuropathy receive any treatment? J Neuroophthalmol 31(1):83\u201388. https:\/\/doi.org\/10.1097\/WNO.0b013e31820d5361","journal-title":"J Neuroophthalmol"},{"key":"4346_CR12","doi-asserted-by":"publisher","first-page":"1044e5","DOI":"10.1016\/j.wneu.2017.07.111","volume":"107","author":"P Dutta","year":"2017","unstructured":"Dutta P, Dhandapani S, Kumar N, Gupta P, Ahuja C, Mukherjee KK (2017) Bevacizumab for Radiation Induced Optic Neuritis among aggressive Residual\/Recurrent Suprasellar Tumors: more than a Mere Antineoplastic Effect. World Neurosurg 107:1044e5\u2013e. https:\/\/doi.org\/10.1016\/j.wneu.2017.07.111. 10","journal-title":"World Neurosurg"},{"issue":"4","key":"4346_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/WNO.0b013e3182607381","volume":"32","author":"O Farooq","year":"2012","unstructured":"Farooq O, Lincoff NS, Saikali N, Prasad D, Miletich RS, Mechtler LL (2012) Novel treatment for radiation optic neuropathy with intravenous bevacizumab. J Neuroophthalmol 32(4):321\u2013324. https:\/\/doi.org\/10.1097\/WNO.0b013e3182607381","journal-title":"J Neuroophthalmol"},{"key":"4346_CR14","doi-asserted-by":"publisher","unstructured":"Aldrees S, Micieli JA (2020) Catastrophic vision loss from radiation-induced optic neuropathy. BMJ Case Rep 13(2). https:\/\/doi.org\/10.1136\/bcr-2019-233706","DOI":"10.1136\/bcr-2019-233706"},{"issue":"3","key":"4346_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/01658107.2020.1817946","volume":"45","author":"FG Ata\u00eddes","year":"2021","unstructured":"Ata\u00eddes FG, Silva SFBR, Baldin JJCM (2021) Radiation-Induced Optic Neuropathy: Literature Review. Neuroophthalmology 45(3):172\u2013180. https:\/\/doi.org\/10.1080\/01658107.2020.1817946","journal-title":"Neuroophthalmology"},{"issue":"2","key":"4346_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jocn.2007.09.004","volume":"15","author":"HV Danesh-Meyer","year":"2008","unstructured":"Danesh-Meyer HV (2008) Radiation-induced optic neuropathy. J Clin Neurosci 15(2):95\u2013100. https:\/\/doi.org\/10.1016\/j.jocn.2007.09.004","journal-title":"J Clin Neurosci"},{"issue":"8","key":"4346_CR17","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/s0161-6420(85)33898-8","volume":"92","author":"LB Kline","year":"1985","unstructured":"Kline LB, Kim JY, Ceballos R (1985) Radiation optic neuropathy. Ophthalmology 92(8):1118\u20131126. https:\/\/doi.org\/10.1016\/s0161-6420(85)33898-8","journal-title":"Ophthalmology"},{"issue":"12","key":"4346_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.bulcan.2019.09.008","volume":"106","author":"A Mohamed Ali","year":"2019","unstructured":"Mohamed Ali A, Mathis T, Bensadoun RJ, Thariat J (2019) Radiation induced optic neuropathy: does treatment modality influence the risk? Bull Cancer 106(12):1160\u20131176. https:\/\/doi.org\/10.1016\/j.bulcan.2019.09.008","journal-title":"Bull Cancer"},{"key":"4346_CR19","first-page":"207","volume":"7","author":"AJ van der Kogel","year":"1986","unstructured":"van der Kogel AJ (1986) Radiation-induced damage in the central nervous system: an interpretation of target cell responses. Br J Cancer Suppl 7:207\u2013217","journal-title":"Br J Cancer Suppl"},{"issue":"6","key":"4346_CR20","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1007\/s12035-017-0695-z","volume":"55","author":"ST Lee","year":"2018","unstructured":"Lee ST, Seo Y, Bae JY, Chu K, Kim JW, Choi SH et al (2018) Loss of Pericytes in Radiation Necrosis after Glioblastoma treatments. Mol Neurobiol 55(6):4918\u20134926. https:\/\/doi.org\/10.1007\/s12035-017-0695-z","journal-title":"Mol Neurobiol"},{"issue":"6","key":"4346_CR21","doi-asserted-by":"publisher","first-page":"e727","DOI":"10.1111\/aos.13797","volume":"96","author":"K Rose","year":"2018","unstructured":"Rose K, Krema H, Durairaj P, Dangboon W, Chavez Y, Kulasekara SI et al (2018) Retinal perfusion changes in radiation retinopathy. Acta Ophthalmol 96(6):e727\u2013e31. https:\/\/doi.org\/10.1111\/aos.13797","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"4346_CR22","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/s0161-6420(82)34611-4","volume":"89","author":"GC Brown","year":"1982","unstructured":"Brown GC, Shields JA, Sanborn G, Augsburger JJ, Savino PJ, Schatz NJ (1982) Radiation retinopathy. Ophthalmology 89(12):1494\u20131501. https:\/\/doi.org\/10.1016\/s0161-6420(82)34611-4","journal-title":"Ophthalmology"},{"issue":"4","key":"4346_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00795-015-0123-2","volume":"48","author":"M Furuse","year":"2015","unstructured":"Furuse M, Nonoguchi N, Kawabata S, Miyatake S, Kuroiwa T (2015) Delayed brain radiation necrosis: pathological review and new molecular targets for treatment. Med Mol Morphol 48(4):183\u2013190. https:\/\/doi.org\/10.1007\/s00795-015-0123-2","journal-title":"Med Mol Morphol"},{"issue":"2","key":"4346_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00066-010-2184-4","volume":"187","author":"C Matuschek","year":"2011","unstructured":"Matuschek C, B\u00f6lke E, Nawatny J, Hoffmann TK, Peiper M, Orth K et al (2011) Bevacizumab as a treatment option for radiation-induced cerebral necrosis. Strahlenther Onkol 187(2):135\u2013139. https:\/\/doi.org\/10.1007\/s00066-010-2184-4","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"4346_CR25","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","volume":"79","author":"VA Levin","year":"2011","unstructured":"Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN et al (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79(5):1487\u20131495. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.12.061","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"4346_CR26","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ijrobp.2018.04.068","volume":"101","author":"Y Xu","year":"2018","unstructured":"Xu Y, Rong X, Hu W, Huang X, Li Y, Zheng D et al (2018) Bevacizumab Monotherapy reduces Radiation-induced brain necrosis in nasopharyngeal carcinoma patients: a Randomized Controlled Trial. Int J Radiat Oncol Biol Phys 101(5):1087\u20131095. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.04.068","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4346_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/ijerph18020670","volume":"18","author":"JH Jung","year":"2021","unstructured":"Jung JH, Kim DJ, Suh K, You J, Lee JH, Joung KI et al (2021) International Price comparisons of Anticancer Drugs: a Scheme for improving patient accessibility. Int J Environ Res Public Health 18(2):670. https:\/\/doi.org\/10.3390\/ijerph18020670","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"4346_CR28","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.clinthera.2006.11.015","volume":"28","author":"T Shih","year":"2006","unstructured":"Shih T, Lindley C (2006) Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 28(11):1779\u20131802. https:\/\/doi.org\/10.1016\/j.clinthera.2006.11.015","journal-title":"Clin Ther"},{"issue":"2","key":"4346_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/pro6.1149","volume":"6","author":"R Mohan","year":"2022","unstructured":"Mohan R (2022) A review of Proton Therapy - current status and future directions. Precis Radiat Oncol 6(2):164\u2013176. https:\/\/doi.org\/10.1002\/pro6.1149","journal-title":"Precis Radiat Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04346-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04346-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04346-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T04:06:33Z","timestamp":1688529993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04346-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4346"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04346-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2865873\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"26 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study that was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Johns Hopkins University School of Medicine Institutional Review Board (IRB00114028).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Amanda Dean Henderson has served on advisory boards for Horizon Therapeutics. The other authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}